Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Oncopeptides Interim / Quarterly Report 2022

Feb 16, 2023

3091_10-k_2023-02-16_196ff56e-02d6-48cd-9972-786756c99094.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

Loading document…

More from Oncopeptides

Annual Report (ESEF) 2026
Apr 28
Major Shareholding Notification 2026
Apr 24
Major Shareholding Notification 2026
Apr 21
Proxy Solicitation & Information Statement 2026
Apr 16
Proxy Solicitation & Information Statement 2026
Apr 16
Major Shareholding Notification 2026
Apr 10
Major Shareholding Notification 2026
Apr 2
Major Shareholding Notification 2026
Mar 31
Share Issue/Capital Change 2026
Mar 31
Share Issue/Capital Change 2026
Mar 31
View all filings →